About Genera

Genera is a spin-out of the Walter and Eliza Hall Institute of Medical Research, Australia’s premier research institute, and is a publicly listed company (ASX:GBI) that develops and commercializes multiplexed molecular diagnostic tests, based on its proprietary AmpaSand bead-based technology.

Genera’s products compete in the global market for molecular diagnostic tests (currently valued at around US$5.3 billion and expected to double in the next five years) and are used by commercial pathology providers. AmpaSand beads are an ideal platform for the kind of medium density multiplexed tests (5-150 analytes) of most use to pathology labs.

We are committed to providing accurate, clinically relevant molecular diagnostic assays to physicians and their patients.

Board of Directors

Mr. Lou Panaccio

Chairman

SEE FULL BIO

+

Mr. Richard Hannebery

Chief Executive Officer

SEE FULL BIO

+

Dr. Karl Poetter, Ph.D.

Founder & Chief Scientific Officer

SEE FULL BIO

+

Mr. David Symons

Non-Executive Director

SEE FULL BIO

+

Mr. Jim Kalokerinos

Non-Executive Director

SEE FULL BIO

+

Senior Executive Team

Mr. Richard Hannebery

Chief Executive Officer

SEE FULL BIO

+

Dr. Karl Poetter, Ph.D.

Founder & Chief Scientific Officer

SEE FULL BIO

+

Ms. Ronda Charkass

Quality Assurance/Regulatory Affairs Manager

SEE FULL BIO

+

Dr. Nick Vandegraaff, Ph.D.

Head of Product Development

SEE FULL BIO

+

Dr. Conan Chow, Ph.D.

Senior Product Development Associate

SEE FULL BIO

+

Mr. Jason Choo

Production Manager

SEE FULL BIO

+